Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
79 studies found for:    "Retinopathy of prematurity"
Show Display Options
Rank Status Study
1 Recruiting Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
2 Withdrawn Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
3 Completed Pain Response During Examination for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Behavioral: suck 12.5% dextrose in water 5 minutes before the procedure
4 Suspended Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Procedure: Ultrasound examination
5 Unknown  Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Condition: Retinopathy of Prematurity
Intervention: Drug: intravitreal injection
6 Completed A Fatty Acids Study in Preventing Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: SMOFlipid;   Drug: Clinoleic
7 Recruiting Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity
Conditions: Bronchopulmonary Dysplasia;   Retinopathy of Prematurity;   Prematurity;   Pulmonary Disease
Intervention:
8 Enrolling by invitation Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Dietary Supplement: docosahexaenoic acid;   Dietary Supplement: sunflower oil
9 Unknown  Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: erythropoietin and early iron supplements
10 Completed
Has Results
Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
Condition: Retinopathy of Prematurity
Interventions: Drug: propranolol;   Drug: sucrose 5%
11 Recruiting RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
12 Completed IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Intervention: Drug: rhIGF-I/rhIGFBP-3
13 Unknown  The Early Treatment for Retinopathy of Prematurity Study (ETROP)
Condition: Retinopathy of Prematurity
Intervention: Procedure: retinal ablation
14 Completed Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
Condition: Retinopathy of Prematurity
Intervention: Drug: intravitreal injection of 0.03ml ranibizumab
15 Unknown  A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention:
16 Completed Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Retinopathy of Prematurity;   Blindness
Interventions: Procedure: Supplemental Oxygen Management;   Procedure: Conventional Oxygen Management
17 Terminated Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
18 Completed Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
19 Recruiting Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey
Condition: Retinopathy of Prematurity
Intervention:
20 Completed Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening
Condition: Retinopathy of Prematurity
Interventions: Other: Sucrose;   Other: Sterile water

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years